The summer and winter Olympic Games have been accompanied by much press coverage of the controversy and confusion over sex tests for sportswomen. Much of this has centred on the eligibility of subjects with androgen insensitivity to compete in women's events. The purpose of this paper is to review the process of sex differentiation and its abnormalities, highlighting those conditions in which biologically active testosterone is secreted which might confer an advantage in women's sporting events.
The historical basis for the need for sex testing has been reviewed by Professor Ferguson-Smith and Dr Ferris'. They pointed out that initially inspection then manual examination of the external genitalia were carried out but these were replaced by sex chromatin testing by the buccal smear method in 1968. The authors heavily criticized this method since they thought it unfairly excluded those with androgen insensitivity or gonadal dysgenesis whom they believe account for the majority of XY females in sport. One problem is that competitors who fail the sex chromatin test withdraw without a diagnosis being made so statistics about those without virilization who are unfairly excluded are difficult to obtain. It is even possible that the proportion of XY females with virilization due to biologically active androgen secretion and a consequent advantage in competitive sport is greater than assumed2. There are several conditions in which this occurs and in order for the nonspecialist to understand the pathogenesis, a review of normal sexual development and differentiation is helpful.
Normal sex development
Sexual differentiation is a complex process starting in the early embryo and being completed with the development of secondary sex characteristics at puberty. The early mammalian embryo has the potential to become either male or female with an inherent trend towards the latter. However, if the chromosomal sex is male then testes develop, and the hormonal secretions from these cause male differentiation of the internal and external genitalia. These processes will now be examined in more detail (for reviews see Bercovitz et al.3 or Batch et al.4) .
Chromosomes
In the human there are 46 chromosomes consisting of 22 pairs of autosomes and two sex chromosomes these being XX in females and XY in males ( Figure 1 ). In the female, part of one X is inactivated and stains heterochromatically (Barr body) in nuclei from buccal scrapings ( Figure 2 ). If more than 20% of these nuclei contain Barr bodies then it can be confidently predicted that at least two X chromosomes are present and the subject is chromatin positive. Chromatin negative subjects have a single X chromo- The ovary does not develop from the undifferentiated state until 3 months. Genes on both X chromosomes and possibly on an autosome are responsible, but whether there is a mechanism similar to the H-Y antigen in the male is uncertain.
Mechanism of testosterone synthesis and androgen action Before discussing male differentiation of the internal and external genitalia it is important to discuss testosterone synthesis and the mechanism of androgen action.
Testosterone is synthesized from cholesterol in a series of enzymatic steps as depicted in Figure 3 . The most potent androgen in the majority of tissues is not in fact testosterone but another steroid called dihydrotestosterone (DHT) which is formed from testosterone within androgen dependent cells by the action of the enzyme 5ot-reductase ( Figure 4) . Full In the female fetus, on the other hand, lack of testosterone leads to atrophy of the Wolffian system and the absence of Mullerian inhibitory substance allows maturation of these structures into the fallopian tubes, uterus and upper part of the vagina ( Figure 5 ).
Differentiation of the external genitalia
In the early embryo there is a common cloaca but from this a urogenital sinus develops which until the seventh fetal week is identical in both sexes. On each side of the sinus there is an inner urethral and outer labioscrotal fold, while anteriorly there is a genital tubercle which is the anlage of the penis. Females going through puberty experience breast development and redistribution of fat to give the female habitus. There is uterine and particularly endometrial growth, the latter undergoing cyclical shedding with the waxing and waning oestrogen levels to give rise to the menses. Female body hair develops following adrenal androgen action.
Non-virilized XY females
There are two main subgroups of females with an XY chromosome constitution and who have no evidence of androgen activity and consequently are not virilized. They are pure XY gonadal dysgenesis5 and complete androgen insensitivity3 4. In the clinical domain patients usually present because they have never menstruated. Some are discovered when siblings of affected individuals are investigated because of the familial nature of the genetic defects, and some because of the finding of gonads in the labial folds.
Pure XY gonadal dysgenesis In the complete form of pure XY gonadal dysgenesis, as well as amenorrhoea there is sexual infantilism with eunuchoidism and lack of breast development. The external and internal genitalia are completely female. The gonads do not develop and are represented by streaks which are thought to be due to failure of H-Y antigen production or action. There is, therefore, no production of sex steroids or MIS which explains the clinical findings. The plasma testosterone and oestradiol are low even for females and the gonadotrophins are high through failure of the inhibitory feedback mechanism. Because the uterus, tubes and vagina are present, cyclical oestrogen-progestogen therapy results in withdrawal bleeding from the endometrium.
Complete androgen insensitivity Subjects with complete androgen insensitivity, also sometimes referred to as testicular feminization, have a feminine appearance ( Figure 6 ). The external genitalia are female ( Figure 7 ) but with a short blind ending vagina, there is excellent breast development and delicate skin devoid of acne. However, the main characteristic is the absence or extreme sparsity of the axillary and pubic hair. The internal genital structures are absent and the gonads, which may be in the pelvis, inguinal canal or labia, are testes devoid of spermatogenesis.
The gonadotrophins are elevated, luteinizing hormone causing Leydig cell hyperplasia and consequent supranormal levels of plasma testosterone even for a male. Testicular secretion of oestradiol is increased but elevation of this steroid is mainly from peripheral conversion from testosterone. Hence the breast development.
The defect is, therefore, one of insensitivity of the tissues to androgen. Studies of DHT uptake by cultured fibroblasts from genital skin have shown deficiency or qualitative abnormality of the androgen receptor. A post-receptor defect is supposed in the few in whom normal androgen receptors have been found. Androgen insensitivity accounts for the failed development of the Wolffian system but the Mullerian ducts regress because of normal testicular production of the inhibitory hormone. Androgen insensitivity enhances the oestrogen induced breast development.
Virilized XY females
There are several subgroups of females with an XY chromosome constitution or genotype who may have some ambiguity of the external genitalia and who may show some signs of virilization at puberty. Clinically it may be the effects of androgen activity which prompt referral rather than the amenorrhoea.
These conditions have been reviewed by Savage6.
Partial androgen insensitivity Insensitivity to androgen encompasses a wide spectrum of abnormalities from complete testicular feminization already described to a normal male habitus but with perineal hypospadias and gynaecomastia (Reifenstein's syndrome). At the female end of this spectrum there are variants of testicular feminization which are caused by partial or incomplete androgen insensitivity. They are similar in every way to those with the complete form of the disorder except at birth there may be some enlargement of the clitoris and slight labioscrotal fusion. At puberty there is some breast development and normal growth of pubic and axillary hair. The derivatives of the Wolffian system are hypoplastic.
The androgen receptor abnormalities are similar to those found in the complete form but some have normal binding. The reason for androgen insensitivity in the latter is obscure.
Incomplete XY gonadal dysgenesis In the incomplete form of pure gonadal dysgenesis there may be some evidence of androgen activity in fetal life in the form of sexual ambiguity but this becomes more apparent at puberty when citoromegaly and facial hirsutes develop. The breasts do not develop.
The internal genitalia may be of either sex but they are rudimentary or hypoplastic. The gonads are dysgenetic testes which may be in streak form with islands of Leydig cells being found at the hilus. It is supposed that there is insufficient androgen from these cells to masculinize the fetus but the levels become significant at puberty under the influence of high levels of luteinizing hormone. The plasma testosterone is thus above the normal female range which differentiates the incomplete form from the complete in which testosterone levels are low. 
Defects in testosterone biosynthesis
All the enzymes involved in testosterone biosynthesis may be completely or partially deficient. In deficiency of cholesterol desmolase, 3,-hydroxysteroid dehydrogenase or 17ot-hydroxylase, cortisol synthesis is also impaired while lack of the first two enzymes decreases mineralocorticoid production. These are, therefore, forms of congenital adrenal hyperplasia which, without recognition and appropriate treatment at birth, cause death from lack of corticosteroids. With treatment some have survived to adulthood and together with deficiency of the other two enzymes involved in testosterone synthesis (17,20-desmolase and 1713-hydroxysteroid dehydrogenase) present a fairly similar clinical picture.
The external genitalia may vary from completely female to ambiguous with a small hypospadic phallus and blind vaginal pouch. At puberty secondary sex characteristics may or may not develop but if they do the combination of virilization (Figure 8 ) and breast development is often recorded.
The Wolffian duct derivatives are absent, rudimentary or normal but female internal genitalia are never found. The gonads are testes, devoid of spermatogenesis and with Leydig cell hyperplasia ( Figure 9 ). They are located in the abdomen, inguinal canal or labia.
The spectrum of abnormalities depends on the degree of enzyme deficiency, those in whom it is complete tending to have a female habitus with low steroid levels, while those with partial defects undergo some virilization. The picture is further complicated because precursors proximal to the enzyme block are produced excessively under stimulation from luteinizing hormone. These can be converted to androgen and oestrogen in the peri- Diagnosis is made after puberty by finding elevated plasma steroid levels on the proximal side of the block and low levels distally, e.g. a higher level of androstenedione and oestrone compared with testosterone and oestradiol is diagnostic of 17p-hydroxysteroid dehydrogenase deficiency (Figure 3) There is no breast development. The incidence of the disorder is relatively high in the Dominican Republic and many of those brought up there as females, at puberty adopt a male gender role.
There are no female internal genital structures. The male internal genitalia, except for the prostate which is tiny, are normal and the vas opens into the vaginal pouch. Normal spermatogenesis occurs and seminal fluid can reveal a normal sperm count.
All these somatic changes are predictable from the known effects of testosterone and DHT. Biochemically after puberty the diagnosis of 5ac-reductase deficiency is suggested by the finding of a high testosterone:DHT ratio. The plasma testosterone level is normal or high for a male while plasma oestradiol is normal. Prepubertally the enzyme deficiency has to be unmasked with studies pre-and post-injection with chorionic gonadotrophin.
Confirmation of 5ot-reductase deficiency can be made with enzyme studies on tissue or cultured fibroblasts from genital skin. The enzyme may be deficient or abnormal.
The reason for the masculinization of the external genitalia at puberty is obscure but may reflect a combination of the high plasma testosterone8 and low but detectable 5ax-reductase activity.
Discussion
The purpose of sex verification testing is to ensure that sportswomen compete on an equal basis9. The problem is that genetic testing, using either the traditional sex chromatin pattern or the recently introduced detection of the male determining gene on the Y chromosome, does not separate out only those who would have an unfair advantage in competition'0. The purpose of this review is to explain the differences between nonvirilized and virilized XY females. The former would theoretically compete on equal terms but the latter would have an unfair advantage because the excessive endogenous testosterone secretion is biologically active. Purely on the basis of genetic tests both groups would be disqualified.
A second problem is that such disorders are extremely rare in the population yet relatively much more frequent following testing of participants at various prestigious sports meetings2. Since there is little follow-up information on diagnoses in these competitors, it is impossible to decide whether the discrepancy is due to excessive numbers of virilized XY females, which is of concern to the Medical Commission of the International Olympic Committee (IOC), or whether some other gene on the Y chromosome is conferring benefit. If the latter then the eligibility of non-virilized XY females may be questioned.
In spite of criticism of genetic testing for sex determination in sport, the IOC continued to use this method in their recent winter and summer Games".
Although using the modern techniques they stated they were backing up questionable results with other evidence to determine sex.
The International Amateur Athletic Federation (IAAF) on the other hand, bowed to pressure from a number of quarters and announced that the buccal smear test would be abandoned'2. Instead all member federations were instructed to arrange for their male and female athletes to undergo a physical examination to ascertain their state of health and gender. The female athlete would then be issued with a gender certificate if not already on the IAAF femininity list.
It follows from the account of the differences between non-virilized and virilized XY females that physical examination, particularly searching for evidence of androgen activity is preferable to genetic testing. However, the latter had to be introduced and is still preferred by sportswomen because they found The XY female in sport: L. J. Hipkin inspection of the genital region demeaning and they resented manual examination'. It is for this reason there is the lack of clinical data referred to; chromatin negative sportswomen preferred to withdraw from competition rather than be investigated.
Not all sports medical officers agree with the IAAF approach, although it seems no different than the pre-employment medical examination required in many occupations. The British team doctor at the Tokyo World Championships refused to carry out such examination, expressing confidence in his ability to assess the gender of team members with their clothes on! It is also rumoured that the IAAF is reconsidering whether to impose femininity testing and this has encouraged an Australian male-tofemale transsexual to train for athletic competition.
Needless to say this controversy and confusion which has received much press and television coverage must cause sportswomen to lack confidence in gender determination methods and to lose faith in the medical profession. A statement that a sportswoman had to withdraw from competition because a routine test showed she was a 'man' only for her to be reinstated 3 years later does not help'0.
As pointed out many times the main problem is in defining sex, and in particular assigning sex on the basis of one characteristic. Based purely on genotype it is true to say that the female chromosome sex is XX and male XY. However, it is the physical appearance or phenotype which is the main determinant of the sex of rearing. Those with 5ot-reductase deficiency regard themselves as female but some change to the male gender role at puberty when the external genitalia appearances change. Similarly there is a spectrum of androgen insensitivity states from testicular feminization through to Reifenstein's syndrome and sex of rearing is selected according to whether the genitalia are masculine or feminine. It is for this reason that throughout this review, the subjects have been referred to as XY females.
There is another aspect and that is psychosocial sex. Transsexuals have the genotype and phenotype of one sex but their sexual orientation is that of the opposite sex. Because of this difference between psyche and soma, transsexuals seek gender reasignment surgery, again showing the importance attached to phenotypic sex.
In clinical practice, XY females are never told they are really men but that they have abnormal gonads which need to be removed because of the risk of tumour development. Testosterone can also be produced excessively in XX females with such conditions as congenital adrenal hyperplasia and the far more common polycystic ovarian syndrome. These can also lead to virilization, so in some ways inspection of the genitalia is to assess androgen status rather than to determine sex. Whether sportswomen would accept this different interpretation for the need for genital inspection is open to speculation. It is of some relevance that there have been no adverse comments about the need for doping control independent sampling officers to view the source of urine during specimen collection.
If genetic testing unfairly disqualifies some female competitors and if women object to phenotypic sex being ascertained by genital inspection or examination, is there any other approach? The International Ski Federation (FIS) carries out serum testosterone estimations as part of their gender verification protocol (Dr Michael Turner, personal communication). This has two advantages; unlike tests of genotype it does not exclude those with complete gonadal dysgenesis, and it is a direct measure of a steroid that could be giving a female competitor an advantage. It has the disadvantage that suppressive medication could be employed to lower plasma testosterone levels. However, random drug control sampling would reveal this or, alternatively, longterm suppression of androgens would cause loss of their virilizing benefit. However, as with genetic tests, assay of plasma testosterone would only be a screen for those requiring physical examination.
Whether sportswomen will develop a different attitude to 'femininity' testing, with better education and with the knowledge there is a general desire to prove eligibility rather than to find grounds for disqualification, remains to be seen. 
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